Skip to main content
Clinical Trials/NCT02177656
NCT02177656
Completed
Not Applicable

Motivational Interviewing Tailored Intervention for Patients With Heart Failure (MITI-HF)

Ruth Masterson-Creber1 site in 1 country100 target enrollmentJanuary 2012
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Ruth Masterson-Creber
Enrollment
100
Locations
1
Primary Endpoint
self-care maintenance
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

This study will test the effectiveness of motivational interviewing and skill building compared to usual care to improve self-care in heart failure (HF) patients. The target population is HF patients recruited from the Hospital of the University of Pennsylvania after an in-patient admission. Patients in the intervention arms will receive one home-visit from a nurse who does a self-care intervention followed up by 3 follow-up phone calls.

Detailed Description

MITI-HF is a prospective, single blinded, pilot randomized single-site trial. The target sample size was 65 participants; however, to account for an estimated 35% attrition rate, the target number for recruitment was 100 participants. We calculated the target sample size based on a 2:1 randomization (intervention: control) with 90% power (5% alpha) to detect a difference of 80% versus 50% (intervention and control group) of scoring over 70, which is the cut-off for adequate self-care at three months between the two groups. The power analysis was performed using G\*Power and confirmed with PASS. Randomization to the intervention or usual care group occurred after the informed consent form was signed and New York Heart Association (NYHA) Functional Class was scored. To achieve balance in both arms of the study, the Minim randomization program was used to minimize prognostic factor differences between groups. Minim stratified participants based on NYHA class and gender to one of two arms in a 2:1 ratio (intervention: control). The research assistants were blinded to group assignment until all study data was collected. All eligible patients were screened for health literacy using a three-question health literacy questionnaire, cognitive impairment using a six-item screener derived from the Mini Mental Status Exam (MMSE), baseline self-care using the SCHFI (v.6.2), and NYHA functional class using the Central Assessment of NYHA Functional Class. A single board-certified cardiologist scored all of the NYHA functional class scores. Medical, socio-demographic, Kansas City Cardiomyopathy Questionnaire (KCCQ), and Heart Failure Somatic Perception Scale (HFSPS) data were collected at baseline via phone call by blinded research assistants (RA) approximately two weeks after hospital discharge. Socio-demographics were assessed using a questionnaire that inquires about gender, age, marital/partnership status, ethnicity/race, and employment. Follow-up data were collected at 90 days by the blinded RAs. If the first call was unsuccessful, the RA would try every 3 to 5 days for up to 60 days. If there was no contact with the participant after 60 days from the expected follow-up date, the participant was considered lost to follow-up. During the follow-up phone call, participants completed the SCHFI, KCCQ, HFSPS and self-reported clinical events within the study period. Self-reported clinical events were verified with a review of the electronic medical record to confirm any hospitalizations, emergency room visits, or outpatient heart failure related visits that occurred within the study period.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
June 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ruth Masterson-Creber
Responsible Party
Sponsor Investigator
Principal Investigator

Ruth Masterson-Creber

Pre-doctoral student in Nursing Science at the University of Pennsylvania

University of Pennsylvania

Eligibility Criteria

Inclusion Criteria

  • To be included, participants had to be:
  • hospitalized with a primary or secondary diagnosis of heart failure
  • able to read and speak English
  • 18 years of age or older
  • living in a setting where they can independently engage in self-care
  • living within 30 miles from the University hospital
  • have at least adequate health literacy
  • symptomatic HF (NYHA II-IV)
  • willing to participate

Exclusion Criteria

  • Exclusion criteria included:
  • being on a Milrinone drip
  • being on a list for an implanted ventricular assist device or heart transplant
  • cognitive impairment with the inability to participate in the intervention or complete the study instruments
  • inability to provide informed consent
  • Study enrollment took place from January 2012 to December 2013.

Outcomes

Primary Outcomes

self-care maintenance

Time Frame: baseline, 90 days

Self-Care will be self-reported and measured using the Self-Care of Heart Failure Index (SCHFI). Items measuring self-care maintenance address treatment adherence and self-monitoring, while management focuses on decision-making in response to symptoms. Higher scores reflect better self-care maintenance. Each scale is scored separately; the total possible score for each scale is 100.

self-care management

Time Frame: baseline, 90 days

Self-Care management will be self-reported and measured using the Self-Care of Heart Failure Index (SCHFI). Self care management is a patients ability to recognize symptoms when they occur; independent and interdependent self-care treatments implemented by the patient (e.g., take an extra diuretic for shortness of breath) and ability to evaluate the effectiveness of the treatments implemented. Higher scores reflect better self-care. Each scale is scored separately; the total possible score for each scale is 100.

self-care confidence

Time Frame: baseline, 90 days

Self-Care confidence will be self-reported and measured using the Self-Care of Heart Failure Index (SCHFI). The SCHFI captures confidence in the ability to perform self-care.

Secondary Outcomes

  • Quality of life(baseline and 90 days)
  • Somatic symptom awareness(baseline and 90 days)
  • Hospitalizations(baseline and 90 days)

Study Sites (1)

Loading locations...

Similar Trials